Infographic
The Efficacy and Safety of an Oral Phosphodiesterase 4B (PDE4B) Inhibitor, BI 1015550, in Patients With Idiopathic Pulmonary Fibrosis (IPF): A Phase 2 Clinical Trial
Reviewed by Elizabeth Volkmann, MD, MS
Reviewed by Elizabeth Volkmann, MD, MS
07/24/2024
Subscribe and Stay Ahead With Daily Industry Insights
First Report Managed Care Newsletter